Appropriate Use
Contents(click an entry for fast navigation to the subject)Avoid the unnecessary use of blood components in clinical practiceExisting national guidanceIndications for transfusionRed cell transfusionsFresh frozen plasma (FFP)PlateletsRecombinant factor VIIaProthrombin complex concentrates (PCC)Assessment of haemorrhageInterpretation of abnormal coagulation testsAssessment and optimisation of patients undergoing planned surgeryIntroductionPerioperative managementDiseasesErythropoietin (*)IronFolic acid (*)Antiplatelet drugsWarfarinJehovah's witnessesDeveloping a blood conservation strategyPreoperative autologous donation (PAD) &Acute normovolaemic haemodilution (ANH)Intraoperative cell salvage (ICS)Postoperative cell salvage (PCS)Pharmacological agentsAntifibrinolyicsTopical sealants (*)Point of care testingUK Cell Salvage Action GroupIntroductionICS competency workbookAdverse event reportingPatient FactsheetsTechnical FactsheetsNewsletters(*) Content under constuction Health Service Circular ObjectiveEnsure the appropriate use of blood and the use of effective alternatives in every clinical practice where blood is transfusedSecure appropriate and cost-effective provision of blood transfusion and alternatives in surgical care
Contents(click an entry for fast navigation to the subject)
Avoid the unnecessary use of blood components in clinical practice
Existing national guidance
Indications for transfusion
Red cell transfusions
Fresh frozen plasma (FFP)
Platelets
Recombinant factor VIIa
Prothrombin complex concentrates (PCC)
Assessment of haemorrhage
Interpretation of abnormal coagulation tests
Assessment and optimisation of patients undergoing planned surgery
Introduction
Perioperative management
Diseases
Erythropoietin (*)
Iron
Folic acid (*)
Antiplatelet drugs
Warfarin
Jehovah's witnesses
Developing a blood conservation strategy
Preoperative autologous donation (PAD) &Acute normovolaemic haemodilution (ANH)
Intraoperative cell salvage (ICS)
Postoperative cell salvage (PCS)
Pharmacological agents
Antifibrinolyics
Topical sealants (*)
Point of care testing
UK Cell Salvage Action Group
ICS competency workbook
Adverse event reporting
Patient Factsheets
Technical Factsheets
Newsletters
(*) Content under constuction
Health Service Circular Objective
This page was last reviewed on 10/09/2009